# CMS RFI: Health Technology Ecosystem â€” Summary

**Document:** CMS-0042-NC; RIN 0938-AV68  
**Agency:** Centers for Medicare & Medicaid Services (CMS), ASTP/ONC, HHS  
**Comment Deadline:** June 16, 2025  
**Contact:** HealthTechRFI@cms.hhs.gov

---

## Purpose & Logistics
- Seeks public input on the digital health product market for Medicare, data interoperability, and health-tech infrastructure.
- Comments accepted via Regulations.gov, mail, or overnight delivery.

## Background
- Builds on the 21st Century Cures Act, Executive Order 13813, Blue Button 2.0, ONC Cures Act, TEFCA, USCDI, and recent CMS/ONC rules.
- Goal: Empower patients with secure, standards-based digital access to health data and foster a patient-centric app ecosystem.

## Document Structure
- **I. Background:** Legislative and regulatory milestones.
- **II. Solicitation of Public Comments:** Objectives, scope, and stakeholder groups.
  - **A. Definitions:** Digital tools, digital health products, health-management apps, care-navigation apps, personal health record apps.
  - **B. Patients & Caregivers (PC-1 to PC-12):** Needs, app features, data access, integration, APIs, standards, HIEs, TEFCA.
  - **C. Providers:** Clinical workflows, EHR APIs, adoption barriers.
  - **D. Payers & Data Providers:** Data-sharing APIs, prior authorization, challenges.
  - **E. Technology Vendors & VBC Orgs:** Certification, interoperability, provider burden, innovation.

## Response Instructions
- Label answers with question code (e.g., PC-1).
- Keep responses clear and concise.
- Optional: include links to screenshots or â‰¤15-minute demo videos.

---

This RFI will inform CMS/ASTP-ONCâ€™s next steps to expand safe, easy digital access to health data and spur innovation in Medicare digital health products.

--- 

# Detailed Breakdown of the RFI

## I. Background
CMS and ASTP/ONC trace their authority to the 21st Century Cures Act (2016) and Executive Order 13813 (2017). Key milestones include Blue Button 2.0 (2018), the Data at the Point of Care API pilot (2019), the 2020 Interoperability & Patient Access and ONC Cures Act final rules, HTI-1 and HTI-2 updates, and the 2024 Prior Authorization final ruleâ€”establishing standards-based FHIR APIs, USCDI, and TEFCA to enable secure data access and spur innovation.

## II. Solicitation of Public Comments
Section II seeks targeted feedback by stakeholder groupâ€”Patients & Caregivers; Providers; Payers & Data Providers; and Technology Vendors & VBC Organizationsâ€”through over 100 questions on use cases, barriers, standards, and policy levers to advance the digital health ecosystem.

### A. Definitions
- Digital tools: web, mobile, or device-based software (including sensors and wearables)
- Digital health products: applications supporting individual health needs
- Health management applications: tools that analyze and guide health decisions
- Care navigation applications: platforms to locate, select, and access care services
- Personal health record apps: software aggregating an individualâ€™s health records for viewing and sharing

### B. Patients & Caregivers (PC-1 to PC-12)
#### PC-1 (ğŸ‘¥-1ï¸âƒ£|ğŸ“±) Desired Apps  
What health-management or care-navigation apps & features do beneficiaries need?
#### PC-2 (ğŸ‘¥-2ï¸âƒ£|ğŸ“‚) Unified Data Access  
Is full personal/family health info available in a single portal? If not, why not?
#### PC-3 (ğŸ‘¥-3ï¸âƒ£|ğŸ‘€) App Awareness  
Which existing apps serve Medicare patients & caregivers today?
#### PC-4 (ğŸ‘¥-4ï¸âƒ£|â“) Missing Features  
Identify gaps in current apps and reasons they havenâ€™t been built.
#### PC-5 (ğŸ‘¥-5ï¸âƒ£|ğŸš€) CMS Role in Adoption  
How should CMS vet, promote, or incentivize digital health products?
#### PC-6 (ğŸ‘¥-6ï¸âƒ£|â™¿) Accessibility & Usability  
Design requirements to make apps easy for less tech-savvy beneficiaries.
#### PC-7 (ğŸ‘¥-7ï¸âƒ£|ğŸ“Š) Real-World Evidence  
Best ways for CMS to collect outcome & cost data on released products.
#### PC-8 (ğŸ‘¥-8ï¸âƒ£|ğŸ”—) Data Availability & Integration  
Valuable but hard-to-get data types and interoperability challenges.
#### PC-9 (ğŸ‘¥-9ï¸âƒ£|ğŸ”Œ) API Enhancements  
Desired new CMS datasets & improvements for Blue Button 2.0.
#### PC-10 (ğŸ‘¥-ğŸ”Ÿ|ğŸ—ºï¸) TEFCA Impact  
Examples of TEFCA improving patient access & suggested tweaks.
#### PC-11 (ğŸ‘¥-1ï¸âƒ£1ï¸âƒ£|ğŸ”„) Health Information Exchanges  
Evaluate HIE data value, accuracy, and model best practices.
#### PC-12 (ğŸ‘¥-1ï¸âƒ£2ï¸âƒ£|ğŸ› ï¸) Operational Use Cases  
Highest-value patient workflows (cost estimates, scheduling, etc.).

### C. Providers
#### PR-1 (ğŸ©º-1ï¸âƒ£|ğŸš€) Provider Adoption  
Incentives & supports for clinicians (incl. rural) to use approved apps.
#### PR-2 (ğŸ©º-2ï¸âƒ£|ğŸ§±) Workflow Barriers  
Obstacles to innovative apps for quality, documentation, billing.
#### PR-3 (ğŸ©º-3ï¸âƒ£|ğŸ“‚) Full EHR Access  
Need & challenges of sharing all data formats within EHRs.
#### PR-4 (ğŸ©º-4ï¸âƒ£|ğŸ“) Admin Workflow Standards  
Standards/policies to let apps handle intake forms, scheduling, etc.
#### PR-5 (ğŸ©º-5ï¸âƒ£|ğŸ”Œ) FHIR API Utilization  
Which FHIR APIs are implemented, use cases, constraints.
#### PR-6 (ğŸ©º-6ï¸âƒ£|ğŸ—ºï¸) TEFCA for Providers  
Impact, improvements, and alternatives to TEFCA.
#### PR-7 (ğŸ©º-7ï¸âƒ£|âš–ï¸) Reducing Burden  
Strategies to lighten provider workload while improving data sharing.
#### PR-8 (ğŸ©º-8ï¸âƒ£|ğŸ“Š) Quality Data Simplification  
Using Bulk FHIR & registries to ease quality reporting.
#### PR-9 (ğŸ©º-9ï¸âƒ£|ğŸ†”) Digital Identity Adoption  
Encouraging acceptance of federated patient credentials.
#### PR-10 (ğŸ©º-ğŸ”Ÿ|ğŸ†”) Credential Impacts  
Effects of mandatory credentials on data flow & directories.
#### PR-11 (ğŸ©º-1ï¸âƒ£1ï¸âƒ£|ğŸ¤) Trust Communities & Identity  
How QHINs etc. can reduce burden yet enhance security.
#### PR-12 (ğŸ©º-1ï¸âƒ£2ï¸âƒ£|ğŸš«) Info-Blocking Exceptions  
Should any exceptions be removed or revised?
#### PR-13 (ğŸ©º-1ï¸âƒ£3ï¸âƒ£|ğŸ’¸) Provider Disincentives  
Most effective penalties for info-blocking providers.
#### PR-14 (ğŸ©º-1ï¸âƒ£4ï¸âƒ£|ğŸ“£) Reporting Info Blocking  
Ways to increase provider complaint submissions.

### D. Payers & Data Providers
#### PA-1 (ğŸ’³-1ï¸âƒ£|ğŸ—ºï¸) TEFCA Limitations  
Policy/technical gaps hindering payer participation.
#### PA-2 (ğŸ’³-2ï¸âƒ£|ğŸš€) Accelerating APIs  
Motivating payers to deploy patient/provider/payer APIs.
#### PA-3 (ğŸ’³-3ï¸âƒ£|ğŸ†”) Digital Identity Acceptance  
Encouraging federated credentials for payer portals.
#### PA-4 (ğŸ’³-4ï¸âƒ£|ğŸ“‡) National Directory Value  
Benefits of a FHIR endpoint directory with identity credentials.
#### PA-5 (ğŸ’³-5ï¸âƒ£|ğŸ“Š) Quality Data Simplification  
Bulk extraction & consolidated reporting ideas.
#### PA-7 (ğŸ’³-7ï¸âƒ£|ğŸ“£) Info-Blocking Complaints  
Promoting payer submissions to ONC complaint portal.

### E. Technology Vendors & VBC Orgs
#### TD-1 (ğŸ’»-1ï¸âƒ£|ğŸš€) Ecosystem Stimulation  
Short- & long-term steps to attract Medicare-focused developers.
#### TD-2 (ğŸ’»-2ï¸âƒ£|ğŸ“ˆ) CMS Data for Innovation  
Most valuable additional CMS & external datasets; access obstacles.
#### TD-3 (ğŸ’»-3ï¸âƒ£|ğŸ†”) Vendor Digital Identity  
Challenges & benefits of credential requirements for devs/networks.
#### TD-4 (ğŸ’»-4ï¸âƒ£|ğŸ”“) Open Standards Promotion  
Encouraging open, public APIs over proprietary ones.
#### TD-5 (ğŸ’»-5ï¸âƒ£|ğŸ“‡) FHIR Directory  
Maintaining & funding a nationwide endpoint directory.
#### TD-6 (ğŸ’»-6ï¸âƒ£|ğŸ—ºï¸) TEFCA Functions  
Unique TEFCA roles vs. alternative frameworks.
#### TD-7 (ğŸ’»-7ï¸âƒ£|ğŸ§©) USCDI Gaps  
USCDI impact, limitations, and expansion ideas.
#### TD-8 (ğŸ’»-8ï¸âƒ£|ğŸ·ï¸) Certification Criteria  
Most effective ONC certification standards.
#### TD-9 (ğŸ’»-9ï¸âƒ£|ğŸ”Œ) API-Centric Certification  
Pros/cons of prioritizing API capability over feature lists.
#### TD-10 (ğŸ’»-ğŸ”Ÿ|ğŸ”) API Condition Compliance  
Ensuring APIs expose full EHI per Cures Act.
#### TD-11 (ğŸ’»-1ï¸âƒ£1ï¸âƒ£|ğŸ“¤) Standard EHI Export  
Need for standardized API-based exports & workflow tweaks.
#### TD-12 (ğŸ’»-1ï¸âƒ£2ï¸âƒ£|âœ…) Endorsing External Networks  
Criteria for CMS backing of non-CMS data sources/networks.
#### TD-13 (ğŸ’»-1ï¸âƒ£3ï¸âƒ£|â™¾ï¸) Full EHI API Opportunities  
New use cases, obstacles, trade-offs vs. USCDI.
#### TD-14 (ğŸ’»-1ï¸âƒ£4ï¸âƒ£|ğŸŒ) Network Connectivity  
Endpoint coverage, connection methods, cross-network linking.
#### TD-15 (ğŸ’»-1ï¸âƒ£5ï¸âƒ£|ğŸ“¦) Bulk FHIR Usage  
Advantages & downsides of broader bulk FHIR adoption.
